Automera

About Automera

Automera is pioneering advancements in autophagy-driven degradation platforms. Using cutting-edge computational chemistry, artificial intelligence, and quantum molecular dynamics, they design chimeric small molecules to target autophagy and specific disease areas with precision and efficiency. Their mission is to build technology that accelerates and reduces the cost of developing better drugs, with a focus on challenging-to-treat targets in areas like cancer, inflammation, and central nervous system disorders.

Products & Services

Degradation Platform:A versatile platform leveraging autophagy-driven degradation to target challenging disease areas such as cancer, inflammation, and central nervous system disorders through dual-binding chimeric small molecules.

Specialties

Autophagy-driven degradation Computational chemistry Artificial intelligence Quantum molecular dynamics Drug development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 16000000 MR: - FA: $16M FAN: 16000000	D: 2023-09-27 FD: 2023-09-27	4 investors

Series A Latest

2023-09-27

$16.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Thong Q. Le

Chief Executive Officer

L

Loong Wang

Chief Technology Officer & Co-Founder

S

Shawn Hoon

Chief Scientific Officer

P

Pearly Ng

Head of Chemistry

N

Nicholas Ktistakis

Senior Group Leader

M

Michael Lazarou

Associate Professor and Co-Founder

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Automera Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised